Back
Biogen, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
BIIB
Biogen, Inc.
Last Price:
$177.32
Seasonality Move:
3.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing selling pressure, which indicates risk of future bearish movement.
Biogen, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 185.01 | Sell |
| 20-day SMA: | 184.89 | Sell |
| 50-day SMA: | 186.02 | Sell |
| 200-day SMA: | 159.23 | Buy |
| 8-day EMA: | 183.43 | Sell |
| 20-day EMA: | 184.94 | Sell |
| 50-day EMA: | 184.03 | Sell |
| 200-day EMA: | 168.23 | Buy |
Biogen, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.06 | Sell |
| Relative Strength Index (14 RSI): | 40.61 | Sell |
| Chaikin Money Flow: | -903290 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (182.13 - 189.05) | Sell |
| Bollinger Bands (100): | (170.83 - 189.43) | Sell |
Biogen, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biogen, Inc. Stock
Is Biogen, Inc. Stock a Buy?
-
Biogen, Inc. share price is 177.34 while BIIB 8-day simple moving average is 185.01, which is a Sell signal.
-
The stock price of BIIB is 177.34 while Biogen, Inc. 20-day SMA is 184.89, which makes it a Sell.
-
Biogen, Inc. 50-day simple moving average is 186.02 while BIIB share price is 177.34, making it a Sell technically.
-
BIIB stock price is 177.34 and Biogen, Inc. 200-day simple moving average is 159.23, creating a Buy signal.
BIIB Technical Analysis vs Fundamental Analysis
Sell
44
Biogen, Inc. (BIIB)
is a Sell
Is Biogen, Inc. a Buy or a Sell?
-
Biogen, Inc. stock is rated a SellThe current Biogen, Inc. [BIIB] share price is $177.34. The Score for BIIB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Biogen, Inc. Stock Info
Market Cap:
25.1B
Price in USD:
177.34
Share Volume:
1.3M
Biogen, Inc. 52-Week Range
52-Week High:
202.41
52-Week Low:
110.04
Sell
44
Biogen, Inc. (BIIB)
is a Sell
Biogen, Inc. Share Price Forecast
-
What is the Biogen, Inc. stock price today?The Biogen, Inc. stock price is 177.34 USD today.
-
Will BIIB stock go up or go down?Biogen, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Biogen, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biogen, Inc. is overvalued.
Is Biogen, Inc. Stock a Buy?
-
Biogen, Inc. share price is 177.34 while BIIB 8-day exponential moving average is 183.43, which is a Sell signal.
-
The stock price of BIIB is 177.34 while Biogen, Inc. 20-day EMA is 184.94, which makes it a Sell.
-
Biogen, Inc. 50-day exponential moving average is 184.03 while BIIB share price is 177.34, making it a Sell technically.
-
BIIB stock price is 177.34 and Biogen, Inc. 200-day simple moving average is 168.23, creating a Buy signal.
Fundamental Analysis of Biogen, Inc.
Is Biogen, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $1.21 per share, an increase this year of $0.69 per share, and an increase next year of $0.24 per share.
Technical Analysis of Biogen, Inc.
Should I short Biogen, Inc. stock?
-
BIIB Moving Average Covergence Divergence (MACD) indicator is -1.06, suggesting Biogen, Inc. is a Sell
-
Biogen, Inc. Relative Strength Index (RSI) is 40.61, which suggest Biogen, Inc. is oversold
-
The Bollinger Bands (25) for Biogen, Inc. is (182.13 - 189.05), which suggest Biogen, Inc. is a Sell
-
The Bollinger Bands (100) for Biogen, Inc. is (170.83 - 189.43), which suggest Biogen, Inc. is a Sell
* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.